845617-19-8

Basic information

• Product Name: 5-Methylsulfonyl-2-(2,2,2-trifluoro-1-Methylethoxy)benzoic acid Methyl ester
• Synonyms: 5-Methylsulfonyl-2-(2,2,2-trifluoro-1-Methylethoxy)benzoic acid Methyl ester
• CAS NO: 845617-19-8
• Molecular Formula: C₁₂H₁₃F₃O₅S
• Molecular Weight: 326.2888296
• Mol File: 845617-19-8.mol

Chemical Properties

• Boiling Point: 422.8±45.0 °C(Predicted)
• Appearance: /
• Density: 1.343±0.06 g/cm3(Predicted)
• CAS DataBase Reference: 5-Methylsulfonyl-2-(2,2,2-trifluoro-1-Methylethoxy)benzoic acid Methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 5-Methylsulfonyl-2-(2,2,2-trifluoro-1-Methylethoxy)benzoic acid Methyl ester(845617-19-8)
• EPA Substance Registry System: 5-Methylsulfonyl-2-(2,2,2-trifluoro-1-Methylethoxy)benzoic acid Methyl ester(845617-19-8)

Safety Data

• Hazardous Substances Data: 845617-19-8(Hazardous Substances Data)

Upstream product

• 212556-43-9 1,1,1-trifluoropropan-2-yl trifluoromethanesulfonate 
• 101371-44-2 methyl 2-hydroxy-5-(methylsulfonyl)benzoate 

Downstream Products

• 845617-20-1 5-Methanesulfonyl-2-((S)-2,2,2-trifluoro-1-methyl-ethoxy)-benzoic acid methyl ester 
• 845617-21-2 5-methanesulfonyl-2-((R)-2,2,2-trifluoro-1-methyl-ethoxy)-benzoic acid methyl ester 

Relevant articles and documents

Substituted phenyl methanone derivatives

The present invention relates to compounds of formula I wherein R1, R2, R3, n, and m, are as defined in the specification and to pharmaceutically acceptable acid addition salts thereof. These compounds are good inhibitors

Substituted phenyl methanones

The present invention relates to compounds of general formula IA or IB wherein X1 and X2 are each independently N or C—R″ and R1, R2,R3, R4, R5, and R6 are as defined

[4-(HETEROARYL) PIPERAZIN-1-YL]-(2,5-SUBSTITUTED -PHENYL)METHANONE DERIVATIVES AS GLYCINE TRANSPORTER 1 (GLYT-1) INHIBITORS FOR THE TREATMENT OF NEUROLOGICAL AND NEUROPSYCHIATRIC DISORDERS

The present invention relates to compounds of the general formula (I) wherein R1 is-OR1’,-SR1’ or is a heterocycloalkyl group; R1’ is lower alkyl, lower alkyl substituted by halogen or is -(CH2)n

Heterocyclic-substituted phenyl methanones

The present invention relates to compounds of formula I wherein R1, R2, and are defined in the specification and to pharmaceutically acceptable acid addition salts thereof.